Vanguard Group Inc Anixa Biosciences Inc Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
56Shares Held
5.54MCall Options Held
0Put Options Held
0-
D.A. Davidson & Co.736KShares$2.58 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC604KShares$2.11 Million0.19% of portfolio
-
Ubs Group Ag531KShares$1.86 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.78 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA331KShares$1.16 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $107M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...